The head of Forest Laboratories, Howard Solomon, is reportedly slated to make $100 million or more from his company’s $25 billion merger with pharmaceutical giant Actavis, according to reports.

Reports say documents recently filed with the US Securities and Exchange Commission suggest Actavis is preparing to acquire Forest, a notice that …read more

Source: Global Competition Law Blogs